Sungkyunkwan University · Medicine
서영호 교수의 연구실은 만성 신장질환의 조기 진단 및 예방에 초점을 맞춘 인구기반 전향적 연구를 수행하고 있습니다. 특히 간기능 지표인 간판효소(GGT)와 체중 변화가 정상체중 범주 내에서도 만성 신장질환 발생에 미치는 영향을 규명하고자 하며, 비만과 신기능 저하 간의 인과관계를 생체정보와 장기 추적 데이터를 바탕으로 분석하고 있습니다. 이는 조기 간병리적 생체지표 탐색과 함께 예방의학적 전략 개발에 기여합니다.
Figures are computed from collected data and may differ slightly.
Our findings, which were obtained from a large work-site cohort and excluded individuals with diabetes and hypertension, indicated that serum GGT may be an early predictor for the development of CKD, independent of baseline confounding factors.
Several recent prospective studies have reported that obesity is associated with an increased risk for chronic kidney disease (CKD), but it is unknown whether weight gain increases the risk for CKD if one remains within the "normal" category of body mass index (BMI). We prospectively followed a cohort of 8792 healthy men who had no known risk factors for CKD and participated in a comprehensive health evaluation program at a large worksite. During 35,927 person-years of follow-up, 427 new inciden
Open papers in the app to read, cite, and organize with AI.
